Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward

Prof Richard Sullivan and Dr André Ilbawi
Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward ( Prof Richard Sullivan and Dr André Ilbawi )
6 Oct 2022

ESMO 2022: Lung roundup

Dr Luis Raez - Memorial Cancer Institute, Miami, USA
ESMO 2022: Lung roundup ( Dr Luis Raez -  Memorial Cancer Institute, Miami, USA )
4 Oct 2022

Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN

Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland
Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN ( Prof Jean Bourhis - University Hospital of Lausanne, Lausanne, Switzerland )
27 Sep 2022

Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC

Dr Namita Ghimire - Nepal Health Research Council (NHRC), Kathmandu, Nepal
Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC ( Dr Namita Ghimire - Nepal Health Research Council (NHRC), Kathmandu, Nepal )
25 Sep 2022

Experience of doing clinical research in Nepal

Dr Bishesh Poudyal - Civil Service Hospital of Nepal, Kathmandu, Nepal
Experience of doing clinical research in Nepal ( Dr Bishesh Poudyal - Civil Service Hospital of Nepal, Kathmandu, Nepal )
25 Sep 2022

Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC

Dr Namita Ghimire - Nepal Health Research Council (NHRC), Kathmandu, Nepal
Ethical Issues in Clinical Research. Getting an IRB approval and role of NHRC ( Dr Namita Ghimire - Nepal Health Research Council (NHRC), Kathmandu, Nepal )
25 Sep 2022

Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer

Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA
Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer ( Dr Sara Tolaney - Dana-Farber Cancer Institute, Boston, USA )
21 Sep 2022

Challenges to developing the quality of complex cancer surgery in LMICs

Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India
Challenges to developing the quality of complex cancer surgery in LMICs ( Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India )
19 Sep 2022

The concept of time toxicity: A patient's perspective

Dr Christopher Booth - Queen's University, Kingston, Canada
The concept of time toxicity: A patient's perspective ( Dr Christopher Booth - Queen's University, Kingston, Canada )
19 Sep 2022

Defining value based care for LMICs

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Defining value based care for LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
18 Sep 2022

Cancer survivors' stories: An African perspective

Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation
Cancer survivors' stories: An African perspective ( Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation )
15 Sep 2022

ESMO 2022: Breast and ovarian trial analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2022: Breast and ovarian trial analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Sep 2022